We are dedicated to customer satisfaction and will do the utmost to respond quickly to your needs. Adaltis promotes its products and services worldwide via a keen network of local distributors and is providing a complete product by a dedicated Customer Care Centre and Service Centre for accurate products support, dedicated instrument & application trainings, troubleshooting sessions. On demand we provide also customized local services related to our products.
Proudly recognized as the world's most reputable leader in laboratory equipment, we specialize in the design and manufacturing of small to medium-sized laboratory equipment. We offer innovative, exciting, and effective high-quality products with evident value. Our customers will not only follow us, but instead, we will captivate them with such expertise, personalized attention, flexibility, goodwill, and professionalism that their referrals will become the primary source of new business.
We are an innovative R&D company dedicated to genetic testing and molecular diagnostics. Tianlong, established in 1997, has been a domestic pioneer in the R&D and production of nucleic acid testing instruments and reagents, providing products and total solutions including nucleic acid extractors (magnetic beads method), PCR thermal cyclers, real-time PCR systems, automatic nucleic acid workstations, and hundreds of compatible kits for extraction and detection. Tianlong products have obtained more than 70 China NMPA approvals and over 120 international approvals and certifications in the European Union, the United States, South Korea, etc. They have been marketed in more than 100 countries and regions worldwide. Tianlong products are now widely applied in clinical diagnostics, epidemic prevention and control, food safety, and scientific research. During the COVID-19 pandemic and other major epidemics, including avian influenza and Ebola, Tianlong products and team have made significant contributions to disease prevention and control.
LTEK CO., LTD has established in Gyeonggi-do, South Korea with innovative life science measurement equipment. Consisting specialized mechanical engineers who develops micro plate reader for bio medical field and global marketing sales assistants. This powerful and life science laboratory targeted measurement equipment will always deliver successful results to your research. LTEK is a global enterprise that is starting to be holding a strong stand in global life science market.
The company’s history began in 1904 when Achille Sclavo discovered anti-anthrax serum, and he founded the Tuscan Serotherapy and Vaccinogenic Institute in Siena.
During the First World War, the Institute extended the production of serums and bacterial vaccines to an industrial level. In 1929 the Institute began the production of anti-diphtheria and anti-tetanus anatoxin and, later, of the smallpox vaccine. In 1934 the first diagnostic product appeared as a medical adjuvant for a correct medical diagnosis. Since then, Sclavo has been recognized as a leading company in IVD.
Currently, Sclavo Diagnostics International SpA. is a Chemic-Pharmaceutical Company whose activities span from Research & Development to Industrialization and Commercialization of IVD, with particular focus on Clinical Chemistry, Plasma and Urinary Coagulation, Serology, Hematology, Microbiology. Sclavo is also an ideal Partner for third party manufacturing.
Main Company’s objective is commercialization of high-quality products aiming at Client’s satisfaction while respecting health and safety of patients, employees and environment.
Shanghai Kehua Bio-engineering Co., Ltd. (KHB) was established in 1981 in Shanghai, and became the first publicly listed company in China’s in vitro diagnostics (IVD) industry when it joined the Shenzhen Stock Exchange in 2004. Today, the group operates nearly 40 subsidiaries across China, Italy, South Korea, and other regions, with a workforce of approximately 2,000 employees.>br/>KHB focuses on five core areas: immunodiagnostics, clinical chemistry, molecular diagnostics, mass spectrometry, and point-of-care testing (POCT). The company provides comprehensive IVD solutions, integrating reagents, instruments, and services. It was the first in China to introduce ELISA reagents for hepatitis B and C, as well as dual-reagent clinical chemistry systems. To date, KHB has developed more than 100 diagnostic instruments and over 700 reagents. Its products have secured over 300 domestic registrations and more than 600 international certifications, including CE marking and FDA approval.
With a strong emphasis on independent research and development, KHB has received numerous scientific awards and operates multiple innovation and research centers in Shanghai. The company collaborates with leading universities and hospitals across China on major national and regional R&D projects—many of which have successfully led to product commercialization.
KHB currently serves over 10,000 hospitals, blood centers, disease control agencies, and research institutions worldwide. Its products are exported to more than 100 countries. Notably, its HIV diagnostic kits have been prequalified by the World Health Organization (WHO) and included in the procurement programs of organizations such as UNICEF and USAID.
Guided by its motto, “Care for Life, Dedicate to Excellence,” KHB aspires to become a cornerstone of the global IVD industry. Through a continued commitment to innovation, collaboration, responsibility, and customer-centricity, the company actively contributes to the advancement of precision medicine and the improvement of global health.
